We serve as outside general counsel for HigherDOSE, a growth stage wellness product and services company. We advise the company on corporate entity structure; equity incentives; intellectual property protection; data privacy, including CCPA and GDPR compliance; FDA compliance; commercial contracts; waivers; product safety and advertising matters.
Outside General Counsel for Growth Stage Wellness Company
You Also May Be Interested In:
Lead Counsel to POINT Biopharma Inc. in its Proposed SPAC Business Combination with Research Alliance Corp. I
Lead Counsel to POINT Biopharma Inc. in connection with its proposed SPAC business combination with Therapeutics Acquisition Corp. d/b/a Research Alliance Corp. I (Nasdaq: RACA), a special purpose acquisition company, sponsored by RA Capital Management. Upon closing, the combined company will be named POINT Biopharma Global Inc. and is expected to be listed on Nasdaq under the ticker symbol “PNT”.
Represented Boston Children’s Hospital with intellectual property, business, and government contracting issues associated with VaccineFinder